Fetal Monitoring Market by Product {Ultrasound (2D, 3D & 4D, and Doppler Imaging), Intrauterine Pressure Catheter (IUPC), Telemetry Solutions, Electronic Fetal Monitoring (EFM) (External & Internal), Fetal Electrodes, Fetal Doppler, Accessories & Consumables, and Other Products}, Method (Invasive and Non-Invasive), Portability (Portable and Non-Portable), Application (Intrapartum Fetal Monitoring and Antepartum Fetal Monitoring): Global Opportunity Analysis and Industry Forecast, 2020–2027
The global fetal monitoring market accounted for $2,931.7 million in 2019 and is expected to reach $4,251.1 million by 2027, registering a CAGR of 5.3% from 2020 to 2027.
Fetal monitoring is vital diagnostic tool used to monitor movement and heart rate of a fetus and maternal contractions. It is a fundamental device used for monitoring uterine contractions during labor. It mainly monitors well-being of fetus and progress of labor. In medical terms, it is referred as medical method to check health of an unborn baby to ensure a safe birth. In addition, it is also used to monitor chronic lung diseases, mental retardation, neonatal diseases, hypothermia, vision & hearing problems, jaundice, and neonatal diseases.
Increase in preterm births & birth rates, rise in technological advancements, increase in need for fetal monitoring during pregnancy, rise in antepartum hemorrhage rate, and premature delivery rate drive the global fetal monitoring market. However, high cost of equipment, stringent regulatory procedures, and low prevalence of birth rates, especially in few developed countries impede the market growth. Further, emerging technologies, such as portable & wireless products and untapped emerging economies offer lucrative opportunities for the market players.
The global fetal monitoring market is segmented on the basis of product, method, portability, application, and geography. By product, it is divided into ultrasound, intrauterine pressure catheter (IUPC), telemetry solutions, electronic fetal monitoring (EFM), fetal electrodes, fetal doppler, accessories, consumables, and other products.
The ultrasound product segment held the largest market share in 2019, owing to technological advancements and a wide array of applications. By method, the market is bifurcated into non-invasive and invasive fetal monitoring methods. The non-invasive method held the highest market share in 2019, owing to advancements in fetal monitoring methods. By application, it is categorized into antepartum fetal monitoring and intrapartum fetal monitoring applications. The antepartum fetal monitoring application was the highest revenue contributor in 2019, while the intrapartum fetal monitoring segment is anticipated to grow at the highest rate. Growth of the intrapartum application segment is high as these applications are mostly carried out during second and third trimesters of pregnancy. This application also reduces the incidences of stillbirths by routinely assessing the risk of fetal death in complicated pregnancies with preexisting maternal conditions such as diabetes mellitus.
Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to factors such as well-equipped and better financed hospitals & clinics, high adoption rate for technologically advanced products, and sophisticated healthcare infrastructure. Moreover, the U.S. is the target area for top players in the market, owing to high awareness about fetal monitoring. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to improvement in healthcare facilities, available disposable income, and rapidly developing economic conditions.
The key players operating in the global fetal monitoring market include GE Healthcare, Analogic Corporation, Fujifilm Sonosite, Inc., Koninklijke Philips N.V., Siemens Healthcare, Medtronic Plc, Getinge Group, Neoventa Medical AB, Natus Medical Incorporated, and OSI Systems, Inc.
KEY BENEFITS FOR STAKEHOLDERS
By Product
North America
The key players profiled in this report include GE Healthcare, Analogic Corporation, Fujifilm Sonosite, Inc., Koninklijke Philips N.V., Siemens Healthcare, Medtronic Plc, Getinge Group, Neoventa Medical AB, Natus Medical Incorporated, and OSI Systems, Inc.
Fetal monitoring is vital diagnostic tool used to monitor movement and heart rate of a fetus and maternal contractions. It is a fundamental device used for monitoring uterine contractions during labor. It mainly monitors well-being of fetus and progress of labor. In medical terms, it is referred as medical method to check health of an unborn baby to ensure a safe birth. In addition, it is also used to monitor chronic lung diseases, mental retardation, neonatal diseases, hypothermia, vision & hearing problems, jaundice, and neonatal diseases.
Increase in preterm births & birth rates, rise in technological advancements, increase in need for fetal monitoring during pregnancy, rise in antepartum hemorrhage rate, and premature delivery rate drive the global fetal monitoring market. However, high cost of equipment, stringent regulatory procedures, and low prevalence of birth rates, especially in few developed countries impede the market growth. Further, emerging technologies, such as portable & wireless products and untapped emerging economies offer lucrative opportunities for the market players.
The global fetal monitoring market is segmented on the basis of product, method, portability, application, and geography. By product, it is divided into ultrasound, intrauterine pressure catheter (IUPC), telemetry solutions, electronic fetal monitoring (EFM), fetal electrodes, fetal doppler, accessories, consumables, and other products.
The ultrasound product segment held the largest market share in 2019, owing to technological advancements and a wide array of applications. By method, the market is bifurcated into non-invasive and invasive fetal monitoring methods. The non-invasive method held the highest market share in 2019, owing to advancements in fetal monitoring methods. By application, it is categorized into antepartum fetal monitoring and intrapartum fetal monitoring applications. The antepartum fetal monitoring application was the highest revenue contributor in 2019, while the intrapartum fetal monitoring segment is anticipated to grow at the highest rate. Growth of the intrapartum application segment is high as these applications are mostly carried out during second and third trimesters of pregnancy. This application also reduces the incidences of stillbirths by routinely assessing the risk of fetal death in complicated pregnancies with preexisting maternal conditions such as diabetes mellitus.
Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to factors such as well-equipped and better financed hospitals & clinics, high adoption rate for technologically advanced products, and sophisticated healthcare infrastructure. Moreover, the U.S. is the target area for top players in the market, owing to high awareness about fetal monitoring. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to improvement in healthcare facilities, available disposable income, and rapidly developing economic conditions.
The key players operating in the global fetal monitoring market include GE Healthcare, Analogic Corporation, Fujifilm Sonosite, Inc., Koninklijke Philips N.V., Siemens Healthcare, Medtronic Plc, Getinge Group, Neoventa Medical AB, Natus Medical Incorporated, and OSI Systems, Inc.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities.
- A comprehensive analysis of the countries in North America, Europe, Asia-Pacific, and LAMEA is provided to determine the existing opportunities.
- The key market players and their strategies have been analyzed to understand the competitive outlook of the market.
By Product
- Ultrasound
- 2D Ultrasound
- 3D & 4D Ultrasound
- Doppler Imaging
- Intrauterine Pressure Catheter (IUPC)
- Telemetry Solutions
- Electronic Fetal Monitoring (EFM)
- External EFM
- Internal EFM
- Fetal Electrodes
- Fetal Doppler
- Accessories & Consumables
- Other Products
- Invasive
- Non-Invasive
- Portable
- Non-Portability
- Intrapartum Fetal Monitoring
- Antepartum Fetal Monitoring
- Hospitals
- Clinics
- Others
North America
- U.S.
- Canada
- Mexico
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- Brazil
- Saudi Arabia
- South Africa
- Turkey
- Rest of LAMEA
- GE Healthcare
- Analogic Corporation
- Fujifilm Sonosite, Inc.
- Koninklijke Philips N.V.
- Siemens Healthcare
- Medtronic Plc
- Getinge Group
- Neoventa Medical AB
- Natus Medical Incorporated
- OSI Systems, Inc.
The key players profiled in this report include GE Healthcare, Analogic Corporation, Fujifilm Sonosite, Inc., Koninklijke Philips N.V., Siemens Healthcare, Medtronic Plc, Getinge Group, Neoventa Medical AB, Natus Medical Incorporated, and OSI Systems, Inc.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Top player positioning
3.2.1.Top investment pockets
3.3.Key forces shaping fetal monitoring industry/market
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in preterm births
3.4.1.2.Perpetual need for fetal monitoring
3.4.1.3.Active government and non-government initiatives
3.4.1.4.Technological advancements
3.4.2.Restraints
3.4.2.1.Stringent regulatory procedures
3.4.2.2.High cost associated with fetal monitoring devices
3.4.2.3.Prevalence of declining birth rates
3.4.3.Opportunity
3.4.3.1.Lucrative opportunities in developing countries
3.4.3.2.Portable and wireless products
3.4.4.Impact Analysis
3.1.Impact analysis of COVID-19 on the fetal monitoring market
3.1.1.Overview
3.1.2.Impact of COVID-19 on fetal monitoring market
CHAPTER 4:FETAL MONITORING MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Ultrasound
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Ultrasound, By type
4.2.2.1.Market size and forecast
4.2.2.2.2D Ultrasound
4.2.2.2.1.Market size and forecast
4.2.2.3.3D & 4D Ultrasound
4.2.2.3.1.Market size and forecast
4.2.2.4.Doppler Imaging
4.2.2.4.1.Market size and forecast
4.3.INTRAUTERINE PRESSURE CATHETER (IUPC)
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.4.TELEMETRY SOLUTIONS
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.5.ELECTRONIC FETAL MONITORING (EFM)
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.2.1.Market size and forecast
4.5.2.2.External EFM
4.5.2.2.1.Market size and forecast
4.5.2.3.Internal EFM
4.5.2.3.1.Market size and forecast
4.6.FETAL ELECTRODES
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.7.FETAL DOPPLER
4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.8.ACCESORIES AND CONSUMABLES
4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast, by region
4.9.OTHER FETAL MONITORING DEVICES
4.9.1.Key market trends, growth factors, and opportunities
4.9.2.Market size and forecast, by region
CHAPTER 5:FETAL MONITORING MARKET, BY PORTABILITY
5.1.Overview
5.1.1.Market size and forecast
5.2.Non-Portable
5.2.1.Market size and forecast
5.3.Portable
5.3.1.Market size and forecast
CHAPTER 6:FETAL MONITORING MARKET, BY METHOD
6.1.Overview
6.1.1.Market size and forecast
6.2.Non-Invasive Method
6.2.1.Market size and forecast
6.3.Invasive Method
6.3.1.Market size and forecast
CHAPTER 7:FETAL MONITORING MARKET, BY APPLICATION
7.1.Overview
7.1.1.Market size and forecast
7.2.Antepartum Fetal Monitoring
7.2.1.Market size and forecast
7.3.Intrapartum Fetal Monitoring
7.3.1.Market size and forecast
CHAPTER 8:FETAL MONITORING MARKET, BY END USER
8.1.Overview
8.1.1.Market size and forecast
8.2.Hospitals
8.2.1.Market size and forecast
8.3.Clinics
8.3.1.Market size and forecast
8.4.Others
8.4.1.Market size and forecast
CHAPTER 9:FETAL MONITORING MARKET, BY REGION
9.1.Overview
Market size and forecast
9.2.North America
9.2.1.Key market trends, growth factors, and opportunities
9.2.2.Market size and forecast, by country
9.2.3.Market size and forecast, by product
9.2.4.Market size and forecast, by portability
9.2.5.Market size and forecast, by method
9.2.6.Market size and forecast, by application
9.2.7.Market size and forecast, by end user
9.2.7.1.U.S. Market size and Forecast
9.2.7.2.Canada market size and forecast
9.2.7.3.Mexico
9.3.Europe
9.3.1.Key market trends, growth factors, and opportunities
9.3.2.Market size and forecast, by country
9.3.3.Market size and forecast, by product
9.3.4.Market size and forecast, by portability
9.3.5.Market size and forecast, by method
9.3.6.Market size and forecast, by application
9.3.7.Market size and forecast, by end user
9.3.7.1.Germany market size and forecast
9.3.7.2.France market size and forecast
9.3.7.3.UK, market size and forecast
9.3.7.4.Italy market size and forecast
9.3.7.5.Spain market size and forecast
9.3.7.6.Rest of Europe market size and forecast
9.4.Asia-Pacific
9.4.1.Key market trends, growth factors, and opportunities
9.4.2.Market size and forecast, by country
9.4.3.Market size and forecast, by product
9.4.4.Market size and forecast, by portability
9.4.5.Market size and forecast, by method
9.4.6.Market size and forecast, by application
9.4.7.Market size and forecast, by end user
9.4.7.1.Japan market size and forecast
9.4.7.2.China market size and forecast
9.4.7.3.India, market size and forecast
9.4.7.4.Australia market size and forecast
9.4.7.5.Rest of Asia-Pacific, market size and forecast
9.5.LAMEA
9.5.1.Key market trends, growth factors, and opportunities
9.5.2.Market size and forecast, by country
9.5.3.Market size and forecast, by product
9.5.4.Market size and forecast, by portability
9.5.5.Market size and forecast, by method
9.5.6.Market size and forecast, by application
9.5.7.Market size and forecast, by end user
9.5.7.1.Brazil
9.5.7.2.South Africa market size and forecast
9.5.7.3.Saudi Arabia
9.5.7.4.Turkey
9.5.7.5.Rest of LAMEA
CHAPTER 10:COMPANY PROFILES
10.1.Analogic Corporation
10.1.1.Company overview
10.1.2.Company snapshot
10.1.3.Operating business segments
10.1.4.Product portfolio
10.1.5.Business performance
10.2.Cardinal Health
10.2.1.Company overview
10.2.2.Company snapshot
10.2.3.Operating business segments
10.2.4.Product portfolio
10.2.5.Business performance
10.3.FUJIFILM Holdings Corporation
10.3.1.Company overview
10.3.2.Company snapshot
10.3.3.Operating business segments
10.3.4.Product portfolio
10.3.5.Business performance
10.4.GENERAL ELECTRIC
10.4.1.Company overview
10.4.2.Company snapshot
10.4.3.Operating business segments
10.4.4.Product portfolio
10.4.5.Business performance
10.4.6.Key strategic moves and developments
10.5.Getinge AB
10.5.1.Company overview
10.5.2.Company snapshot
10.5.3.Operating business segments
10.5.4.Product portfolio
10.5.5.Business performance
10.6.Koninklijke Philips N.V. (Philips Healthcare)
10.6.1.Company overview
10.6.2.Company snapshot
10.6.3.Operating business segments
10.6.4.Product portfolio
10.6.5.Business performance
10.6.6.Key strategic moves and developments
10.7.Natus Medical Incorporated
10.7.1.Company overview
10.7.2.Company snapshot
10.7.3.Operating business segments
10.7.4.Product portfolio
10.7.5.Business performance
10.8.Neoventa Medical AB
10.8.1.Company overview
10.8.2.Company snapshot
10.8.3.Operating business segments
10.8.4.Product portfolio
10.8.5.Key strategic moves and developments
10.9.OSI Systems, Inc.
10.9.1.Company overview
10.9.2.Company snapshot
10.9.3.Operating business segments
10.9.4.Product portfolio
10.9.5.Business performance
10.10.SIEMENS AG (Siemens Healthineers)
10.10.1.Company overview
10.10.2.Company snapshot
10.10.3.Operating business segments
10.10.4.Product portfolio
10.10.5.Business performance
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Top player positioning
3.2.1.Top investment pockets
3.3.Key forces shaping fetal monitoring industry/market
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in preterm births
3.4.1.2.Perpetual need for fetal monitoring
3.4.1.3.Active government and non-government initiatives
3.4.1.4.Technological advancements
3.4.2.Restraints
3.4.2.1.Stringent regulatory procedures
3.4.2.2.High cost associated with fetal monitoring devices
3.4.2.3.Prevalence of declining birth rates
3.4.3.Opportunity
3.4.3.1.Lucrative opportunities in developing countries
3.4.3.2.Portable and wireless products
3.4.4.Impact Analysis
3.1.Impact analysis of COVID-19 on the fetal monitoring market
3.1.1.Overview
3.1.2.Impact of COVID-19 on fetal monitoring market
CHAPTER 4:FETAL MONITORING MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Ultrasound
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Ultrasound, By type
4.2.2.1.Market size and forecast
4.2.2.2.2D Ultrasound
4.2.2.2.1.Market size and forecast
4.2.2.3.3D & 4D Ultrasound
4.2.2.3.1.Market size and forecast
4.2.2.4.Doppler Imaging
4.2.2.4.1.Market size and forecast
4.3.INTRAUTERINE PRESSURE CATHETER (IUPC)
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.4.TELEMETRY SOLUTIONS
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.5.ELECTRONIC FETAL MONITORING (EFM)
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.2.1.Market size and forecast
4.5.2.2.External EFM
4.5.2.2.1.Market size and forecast
4.5.2.3.Internal EFM
4.5.2.3.1.Market size and forecast
4.6.FETAL ELECTRODES
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.7.FETAL DOPPLER
4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.8.ACCESORIES AND CONSUMABLES
4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast, by region
4.9.OTHER FETAL MONITORING DEVICES
4.9.1.Key market trends, growth factors, and opportunities
4.9.2.Market size and forecast, by region
CHAPTER 5:FETAL MONITORING MARKET, BY PORTABILITY
5.1.Overview
5.1.1.Market size and forecast
5.2.Non-Portable
5.2.1.Market size and forecast
5.3.Portable
5.3.1.Market size and forecast
CHAPTER 6:FETAL MONITORING MARKET, BY METHOD
6.1.Overview
6.1.1.Market size and forecast
6.2.Non-Invasive Method
6.2.1.Market size and forecast
6.3.Invasive Method
6.3.1.Market size and forecast
CHAPTER 7:FETAL MONITORING MARKET, BY APPLICATION
7.1.Overview
7.1.1.Market size and forecast
7.2.Antepartum Fetal Monitoring
7.2.1.Market size and forecast
7.3.Intrapartum Fetal Monitoring
7.3.1.Market size and forecast
CHAPTER 8:FETAL MONITORING MARKET, BY END USER
8.1.Overview
8.1.1.Market size and forecast
8.2.Hospitals
8.2.1.Market size and forecast
8.3.Clinics
8.3.1.Market size and forecast
8.4.Others
8.4.1.Market size and forecast
CHAPTER 9:FETAL MONITORING MARKET, BY REGION
9.1.Overview
Market size and forecast
9.2.North America
9.2.1.Key market trends, growth factors, and opportunities
9.2.2.Market size and forecast, by country
9.2.3.Market size and forecast, by product
9.2.4.Market size and forecast, by portability
9.2.5.Market size and forecast, by method
9.2.6.Market size and forecast, by application
9.2.7.Market size and forecast, by end user
9.2.7.1.U.S. Market size and Forecast
9.2.7.2.Canada market size and forecast
9.2.7.3.Mexico
9.3.Europe
9.3.1.Key market trends, growth factors, and opportunities
9.3.2.Market size and forecast, by country
9.3.3.Market size and forecast, by product
9.3.4.Market size and forecast, by portability
9.3.5.Market size and forecast, by method
9.3.6.Market size and forecast, by application
9.3.7.Market size and forecast, by end user
9.3.7.1.Germany market size and forecast
9.3.7.2.France market size and forecast
9.3.7.3.UK, market size and forecast
9.3.7.4.Italy market size and forecast
9.3.7.5.Spain market size and forecast
9.3.7.6.Rest of Europe market size and forecast
9.4.Asia-Pacific
9.4.1.Key market trends, growth factors, and opportunities
9.4.2.Market size and forecast, by country
9.4.3.Market size and forecast, by product
9.4.4.Market size and forecast, by portability
9.4.5.Market size and forecast, by method
9.4.6.Market size and forecast, by application
9.4.7.Market size and forecast, by end user
9.4.7.1.Japan market size and forecast
9.4.7.2.China market size and forecast
9.4.7.3.India, market size and forecast
9.4.7.4.Australia market size and forecast
9.4.7.5.Rest of Asia-Pacific, market size and forecast
9.5.LAMEA
9.5.1.Key market trends, growth factors, and opportunities
9.5.2.Market size and forecast, by country
9.5.3.Market size and forecast, by product
9.5.4.Market size and forecast, by portability
9.5.5.Market size and forecast, by method
9.5.6.Market size and forecast, by application
9.5.7.Market size and forecast, by end user
9.5.7.1.Brazil
9.5.7.2.South Africa market size and forecast
9.5.7.3.Saudi Arabia
9.5.7.4.Turkey
9.5.7.5.Rest of LAMEA
CHAPTER 10:COMPANY PROFILES
10.1.Analogic Corporation
10.1.1.Company overview
10.1.2.Company snapshot
10.1.3.Operating business segments
10.1.4.Product portfolio
10.1.5.Business performance
10.2.Cardinal Health
10.2.1.Company overview
10.2.2.Company snapshot
10.2.3.Operating business segments
10.2.4.Product portfolio
10.2.5.Business performance
10.3.FUJIFILM Holdings Corporation
10.3.1.Company overview
10.3.2.Company snapshot
10.3.3.Operating business segments
10.3.4.Product portfolio
10.3.5.Business performance
10.4.GENERAL ELECTRIC
10.4.1.Company overview
10.4.2.Company snapshot
10.4.3.Operating business segments
10.4.4.Product portfolio
10.4.5.Business performance
10.4.6.Key strategic moves and developments
10.5.Getinge AB
10.5.1.Company overview
10.5.2.Company snapshot
10.5.3.Operating business segments
10.5.4.Product portfolio
10.5.5.Business performance
10.6.Koninklijke Philips N.V. (Philips Healthcare)
10.6.1.Company overview
10.6.2.Company snapshot
10.6.3.Operating business segments
10.6.4.Product portfolio
10.6.5.Business performance
10.6.6.Key strategic moves and developments
10.7.Natus Medical Incorporated
10.7.1.Company overview
10.7.2.Company snapshot
10.7.3.Operating business segments
10.7.4.Product portfolio
10.7.5.Business performance
10.8.Neoventa Medical AB
10.8.1.Company overview
10.8.2.Company snapshot
10.8.3.Operating business segments
10.8.4.Product portfolio
10.8.5.Key strategic moves and developments
10.9.OSI Systems, Inc.
10.9.1.Company overview
10.9.2.Company snapshot
10.9.3.Operating business segments
10.9.4.Product portfolio
10.9.5.Business performance
10.10.SIEMENS AG (Siemens Healthineers)
10.10.1.Company overview
10.10.2.Company snapshot
10.10.3.Operating business segments
10.10.4.Product portfolio
10.10.5.Business performance
LIST OF TABLES
TABLE 01.GLOBAL FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.ULTRASOUND MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.FETAL MONITORING MARKET FOR INTRAUTERINE PRESSURE CATHETER (IUPC), BY REGION, 2019–2027 ($MILLION)
TABLE 04.FETAL MONITORING MARKET FOR TELEMETRY SOLUTIONS, BY REGION, 2019–2027 ($MILLION)
TABLE 05.ELECTRONIC FETAL MONITORING, BY REGION, 2019–2027 ($MILLION)
TABLE 06.ELECTRONIC FETAL MONITORING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.FETAL MONITORING MARKET FOR FETAL ELECTRODE, BY REGION, 2019–2027 ($MILLION)
TABLE 08.FETAL DOPPLER MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.ACCESSORIES AND CONSUMABLES MARKET FOR OBTURATOR, BY REGION, 2019–2027 ($MILLION)
TABLE 10.FETAL MONITORING MARKET FOR OTHER FETAL MONITORING DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 11.FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 12.FETAL MONITORING MARKET FOR NON-PORTABLE, BY REGION, 2019–2027 ($MILLION)
TABLE 13.FETAL MONITORING MARKET FOR PORTABLE, BY REGION, 2019–2027 ($MILLION)
TABLE 14.FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 15.FETAL MONITORING MARKET FOR NON-INVASIVE METHOD, BY REGION, 2019–2027 ($MILLION)
TABLE 16.FETAL MONITORING MARKET FOR INVASIVE METHOD, BY REGION, 2019–2027 ($MILLION)
TABLE 17.FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 18.FETAL MONITORING MARKET FOR ANTEPARTUM FETAL MONITORING, BY REGION, 2019–2027 ($MILLION)
TABLE 19.FETAL MONITORING MARKET FOR INTRAPARTUM FETAL MONITORING, BY REGION, 2019–2027 ($MILLION)
TABLE 20.FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 21.FETAL MONITORING MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 22.FETAL MONITORING MARKET FOR CLINICS, BY REGION, 2019–2027 ($MILLION)
TABLE 23.FETAL MONITORING MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 24.FETAL MONITORING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 25.NORTH AMERICA FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 26.NORTH AMERICA FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 27.NORTH AMERICA FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 28.NORTH AMERICA FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 29.NORTH AMERICA FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 30.NORTH AMERICA FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 31.EUROPE FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 32.EUROPE FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 33.EUROPE FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 34.EUROPE FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 35.EUROPE FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 36.EUROPE FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 37.ASIA-PACIFIC FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 38.ASIA-PACIFIC FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 39.ASIA-PACIFIC FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 40.ASIA-PACIFIC FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 41.ASIA-PACIFIC FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 42.ASIA-PACIFIC FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 43.LAMEA FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 44.LAMEA FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 45.LAMEA FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 46.LAMEA FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 47.LAMEA FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 48.LAMEA FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 49.ANALOGIC: COMPANY SNAPSHOT
TABLE 50.ANALOGIC: OPERATING SEGMENTS
TABLE 51.ANALOGIC:PRODUCT PORTFOLIO
TABLE 52.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 53.CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 54.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 55.FUJIFILM: COMPANY SNAPSHOT
TABLE 56.FUJIFILM HOLDINGS CORPORATION: PRODUCT SEGMENTS
TABLE 57.FUJIFILM: PRODUCT PORTFOLIO
TABLE 58.GE.: COMPANY SNAPSHOT
TABLE 59.GE.: OPERATING SEGMENTS
TABLE 60.GE: PRODUCT PORTFOLIO
TABLE 61.GETINGE: COMPANY SNAPSHOT
TABLE 62.GETINGE: OPERATING SEGMENTS
TABLE 63.GETINGE: PRODUCT PORTFOLIO:
TABLE 64.PHILIPS: COMPANY SNAPSHOT
TABLE 65.PHILIPS: OPERATING SEGMENTS
TABLE 66.PHILIPS: PRODUCT PORTFOLIO
TABLE 67.NATUS: COMPANY SNAPSHOT
TABLE 68.NATUS: OPERATING SEGMENTS
TABLE 69.NATUS: PRODUCT PORTFOLIO
TABLE 70.NEOVENTA: COMPANY SNAPSHOT
TABLE 71.NEOVENTA: OPERATING SEGMENTS
TABLE 72.NEOVENTA: PRODUCT PORTFOLIO
TABLE 73.OSI: COMPANY SNAPSHOT
TABLE 74.OSI: OPERATING SEGMENTS
TABLE 75.OSI: PRODUCT PORTFOLIO
TABLE 76.SIEMENS: COMPANY SNAPSHOT
TABLE 77.SIEMENS: OPERATING SEGMENTS
TABLE 78.SIEMENS: PRODUCT PORTFOLIO
TABLE 01.GLOBAL FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.ULTRASOUND MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.FETAL MONITORING MARKET FOR INTRAUTERINE PRESSURE CATHETER (IUPC), BY REGION, 2019–2027 ($MILLION)
TABLE 04.FETAL MONITORING MARKET FOR TELEMETRY SOLUTIONS, BY REGION, 2019–2027 ($MILLION)
TABLE 05.ELECTRONIC FETAL MONITORING, BY REGION, 2019–2027 ($MILLION)
TABLE 06.ELECTRONIC FETAL MONITORING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.FETAL MONITORING MARKET FOR FETAL ELECTRODE, BY REGION, 2019–2027 ($MILLION)
TABLE 08.FETAL DOPPLER MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.ACCESSORIES AND CONSUMABLES MARKET FOR OBTURATOR, BY REGION, 2019–2027 ($MILLION)
TABLE 10.FETAL MONITORING MARKET FOR OTHER FETAL MONITORING DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 11.FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 12.FETAL MONITORING MARKET FOR NON-PORTABLE, BY REGION, 2019–2027 ($MILLION)
TABLE 13.FETAL MONITORING MARKET FOR PORTABLE, BY REGION, 2019–2027 ($MILLION)
TABLE 14.FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 15.FETAL MONITORING MARKET FOR NON-INVASIVE METHOD, BY REGION, 2019–2027 ($MILLION)
TABLE 16.FETAL MONITORING MARKET FOR INVASIVE METHOD, BY REGION, 2019–2027 ($MILLION)
TABLE 17.FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 18.FETAL MONITORING MARKET FOR ANTEPARTUM FETAL MONITORING, BY REGION, 2019–2027 ($MILLION)
TABLE 19.FETAL MONITORING MARKET FOR INTRAPARTUM FETAL MONITORING, BY REGION, 2019–2027 ($MILLION)
TABLE 20.FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 21.FETAL MONITORING MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 22.FETAL MONITORING MARKET FOR CLINICS, BY REGION, 2019–2027 ($MILLION)
TABLE 23.FETAL MONITORING MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 24.FETAL MONITORING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 25.NORTH AMERICA FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 26.NORTH AMERICA FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 27.NORTH AMERICA FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 28.NORTH AMERICA FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 29.NORTH AMERICA FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 30.NORTH AMERICA FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 31.EUROPE FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 32.EUROPE FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 33.EUROPE FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 34.EUROPE FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 35.EUROPE FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 36.EUROPE FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 37.ASIA-PACIFIC FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 38.ASIA-PACIFIC FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 39.ASIA-PACIFIC FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 40.ASIA-PACIFIC FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 41.ASIA-PACIFIC FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 42.ASIA-PACIFIC FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 43.LAMEA FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 44.LAMEA FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 45.LAMEA FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 46.LAMEA FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 47.LAMEA FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 48.LAMEA FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 49.ANALOGIC: COMPANY SNAPSHOT
TABLE 50.ANALOGIC: OPERATING SEGMENTS
TABLE 51.ANALOGIC:PRODUCT PORTFOLIO
TABLE 52.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 53.CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 54.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 55.FUJIFILM: COMPANY SNAPSHOT
TABLE 56.FUJIFILM HOLDINGS CORPORATION: PRODUCT SEGMENTS
TABLE 57.FUJIFILM: PRODUCT PORTFOLIO
TABLE 58.GE.: COMPANY SNAPSHOT
TABLE 59.GE.: OPERATING SEGMENTS
TABLE 60.GE: PRODUCT PORTFOLIO
TABLE 61.GETINGE: COMPANY SNAPSHOT
TABLE 62.GETINGE: OPERATING SEGMENTS
TABLE 63.GETINGE: PRODUCT PORTFOLIO:
TABLE 64.PHILIPS: COMPANY SNAPSHOT
TABLE 65.PHILIPS: OPERATING SEGMENTS
TABLE 66.PHILIPS: PRODUCT PORTFOLIO
TABLE 67.NATUS: COMPANY SNAPSHOT
TABLE 68.NATUS: OPERATING SEGMENTS
TABLE 69.NATUS: PRODUCT PORTFOLIO
TABLE 70.NEOVENTA: COMPANY SNAPSHOT
TABLE 71.NEOVENTA: OPERATING SEGMENTS
TABLE 72.NEOVENTA: PRODUCT PORTFOLIO
TABLE 73.OSI: COMPANY SNAPSHOT
TABLE 74.OSI: OPERATING SEGMENTS
TABLE 75.OSI: PRODUCT PORTFOLIO
TABLE 76.SIEMENS: COMPANY SNAPSHOT
TABLE 77.SIEMENS: OPERATING SEGMENTS
TABLE 78.SIEMENS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL FETAL MONITORING MARKET SEGMENTATION
FIGURE 02.TOP PLAYER POSITIONING, 2019
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
FIGURE 06.MODERATE THREAT OF SUBSTITUTES
FIGURE 07.MODERATE INTENSITY OF RIVALRY
FIGURE 08.HIGH THREAT OF NEW ENTRANT
FIGURE 09.IMPACT ANALYSES, FETAL MONITORING MARKET
FIGURE 10.FETAL MONITORING MARKET FOR 2D ULTRASOUND MARKET, 2019–2027 ($MILLION)
FIGURE 11.FETAL MONITORING MARKET FOR 3D & 4D ULTRASOUND MARKET, 2019–2027 ($MILLION)
FIGURE 12.FETAL MONITORING MARKET FOR DOPPLER IMAGING, 2019–2027 ($MILLION)
FIGURE 13.FETAL MONITORING MARKET, 2020–2027 ($MILLION)
FIGURE 14.FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 15.U.S.FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 16.CANADA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 17.MEXICO FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 18.GERMANY FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 19.FRANCE FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 20.UK FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 21.ITALY FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 22.SPAIN FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 23.REST OF EUROPE FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 24.JAPAN FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 25.CHINA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 26.INDIA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 27.AUSTRALIA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 28.REST OF ASIA-PACIFIC FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 29.BRAZIL FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 30.SOUTH AFRICA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 31.SAUDI ARABIA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 32.TURKEY FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 33.REST OF LAMEA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 34.ANALOGIC: NET SALES, 2015–2017 ($MILLION)
FIGURE 35.ANALOGIC: REVENUE SHARE, BY SEGMENT, 2017(%)
FIGURE 36.ANALOGIC: REVENUE SHARE, BY REGION, 2017(%)
FIGURE 37.CARDINAL HEALTH: NET SALES, 2017–2019 ($MILLION)
FIGURE 38.CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 39.CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 40.FUJIFILM: NET SALES, 2016–2018 ($MILLION)
FIGURE 41.FUJIFILM: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 42.GE: NET SALES, 2016–2018 ($MILLION)
FIGURE 43.GE: REVENUE SHARE, BY SEGMENT, 2018(%)
FIGURE 44.GE: REVENUE SHARE, BY REGION, 2018(%)
FIGURE 45.GETINGE: NET SALES, 2016–2018 ($MILLION)
FIGURE 46.GETINGE: REVENUE SHARE, BY SEGMENTS, 2018 (%)
FIGURE 47.GETINGE: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 48.PHILIPS: NET SALES, 2017–2018 ($MILLION)
FIGURE 49.PHILIPS REVENUE SHARE, BY SEGMENTS, 2018 (%)
FIGURE 50.PHILIPS: REVENUE SHARE, BY REGIONS, 2018 (%)
FIGURE 51.NATUS: NET SALES, 2016–2018 ($MILLION)
FIGURE 52.NATUS: REVENUE SHARE, BY SEGMENT, 2018(%)
FIGURE 53.NATUS: REVENUE SHARE, BY REGION, 2018(%)
FIGURE 54.OSI SYSTEMS, INC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 55.OSI: REVENUE SHARE, BY SEGMENTS, 2019 (%)
FIGURE 56.OSI: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 57.NET SALES, 2016–2018 ($MILLION)
FIGURE 58.SIEMENS: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 59.SIEMENS: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 01.GLOBAL FETAL MONITORING MARKET SEGMENTATION
FIGURE 02.TOP PLAYER POSITIONING, 2019
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
FIGURE 06.MODERATE THREAT OF SUBSTITUTES
FIGURE 07.MODERATE INTENSITY OF RIVALRY
FIGURE 08.HIGH THREAT OF NEW ENTRANT
FIGURE 09.IMPACT ANALYSES, FETAL MONITORING MARKET
FIGURE 10.FETAL MONITORING MARKET FOR 2D ULTRASOUND MARKET, 2019–2027 ($MILLION)
FIGURE 11.FETAL MONITORING MARKET FOR 3D & 4D ULTRASOUND MARKET, 2019–2027 ($MILLION)
FIGURE 12.FETAL MONITORING MARKET FOR DOPPLER IMAGING, 2019–2027 ($MILLION)
FIGURE 13.FETAL MONITORING MARKET, 2020–2027 ($MILLION)
FIGURE 14.FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 15.U.S.FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 16.CANADA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 17.MEXICO FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 18.GERMANY FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 19.FRANCE FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 20.UK FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 21.ITALY FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 22.SPAIN FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 23.REST OF EUROPE FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 24.JAPAN FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 25.CHINA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 26.INDIA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 27.AUSTRALIA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 28.REST OF ASIA-PACIFIC FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 29.BRAZIL FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 30.SOUTH AFRICA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 31.SAUDI ARABIA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 32.TURKEY FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 33.REST OF LAMEA FETAL MONITORING MARKET, 2019–2027 ($MILLION)
FIGURE 34.ANALOGIC: NET SALES, 2015–2017 ($MILLION)
FIGURE 35.ANALOGIC: REVENUE SHARE, BY SEGMENT, 2017(%)
FIGURE 36.ANALOGIC: REVENUE SHARE, BY REGION, 2017(%)
FIGURE 37.CARDINAL HEALTH: NET SALES, 2017–2019 ($MILLION)
FIGURE 38.CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 39.CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 40.FUJIFILM: NET SALES, 2016–2018 ($MILLION)
FIGURE 41.FUJIFILM: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 42.GE: NET SALES, 2016–2018 ($MILLION)
FIGURE 43.GE: REVENUE SHARE, BY SEGMENT, 2018(%)
FIGURE 44.GE: REVENUE SHARE, BY REGION, 2018(%)
FIGURE 45.GETINGE: NET SALES, 2016–2018 ($MILLION)
FIGURE 46.GETINGE: REVENUE SHARE, BY SEGMENTS, 2018 (%)
FIGURE 47.GETINGE: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 48.PHILIPS: NET SALES, 2017–2018 ($MILLION)
FIGURE 49.PHILIPS REVENUE SHARE, BY SEGMENTS, 2018 (%)
FIGURE 50.PHILIPS: REVENUE SHARE, BY REGIONS, 2018 (%)
FIGURE 51.NATUS: NET SALES, 2016–2018 ($MILLION)
FIGURE 52.NATUS: REVENUE SHARE, BY SEGMENT, 2018(%)
FIGURE 53.NATUS: REVENUE SHARE, BY REGION, 2018(%)
FIGURE 54.OSI SYSTEMS, INC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 55.OSI: REVENUE SHARE, BY SEGMENTS, 2019 (%)
FIGURE 56.OSI: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 57.NET SALES, 2016–2018 ($MILLION)
FIGURE 58.SIEMENS: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 59.SIEMENS: REVENUE SHARE, BY REGION, 2018 (%)
